Biodesix (BDSX) Depreciation and Depletion (2019 - 2026)

Biodesix has reported Depreciation and Depletion for 8 years, with the latest figure at $900000.0 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation and Depletion changed 0.0% year-over-year to $900000.0; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (down 5.92% YoY), and the FY2025 full-year result was $3.6 million, down 3.27% from the prior year.
• Depreciation and Depletion for Q1 2026 stood at $900000.0, up from $842000.0 in the prior quarter.
• The five-year high for Depreciation and Depletion was $1.0 million in Q3 2024, with the low at -$440000.0 in Q4 2023.
• Historically, Depreciation and Depletion has averaged $605235.3 across 5 years, with a median of $842000.0 in 2025.
• Annual changes were most pronounced in 2023 — Depreciation and Depletion sank 204.27% — and 2024, when it jumped 319.32%.
• Biodesix's Depreciation and Depletion stood at $422000.0 in 2022, then slumped by 204.27% to -$440000.0 in 2023, then jumped by 319.32% to $965000.0 in 2024, then dropped by 12.75% to $842000.0 in 2025, then gained by 6.89% to $900000.0 in 2026.
• The last three Depreciation and Depletion figures came in at $900000.0 (Q1 2026), $842000.0 (Q4 2025), and $900000.0 (Q3 2025), per Business Quant data.